Zobrazeno 31 - 40
of 457
pro vyhledávání: '"Noel Milpied"'
Autor:
Grzegorz W. Basak, Boris V. Afanasyev, Péter Reményi, Noel Milpied, Paolo Corradini, Madan Jagasia, Olaf Penack, Henrik Sengeloev, Frank Kroschinsky, Zinaida Peric, Ibrahim Yakoub-Agha, Rafael F. Duarte, Dietger Niederwieser, Edward Kanfer, Steffie van der Werf, Fabio Ciceri, Alessandro Rambaldi, Didier Blaise, Patrice Chevallier, Carlos Solano, Hildegard Greinix, Eric Beohou, Luca Castagna, Nicolaus Kröger, Hélène Schoemans, Agnieszka Tomaszewska, Christian Koenecke, Jean Bourhis, Benedetto Bruno, Christof Scheid, Marco Ladetto, Gérard Socié
Publikováno v:
Frontiers in Immunology
Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954
Frontiers in Immunology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954
Frontiers in Immunology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Rituximab (R) is increasingly incorporated in reduced intensity conditioning (RIC) regimens for allogeneic hematopoietic cell transplantation (alloHCT) in patients with B-cell malignancies, not only to improve disease control, but also to prevent gra
Autor:
Ibrahim Yakoub-Agha, Corrado Tarella, Linda Koster, Emanuele Angelucci, Nicolaus Kröger, Fabio Ciceri, Andrew M. McDonald, Yener Koc, Meral Beksac, Concepcion Herrera Arroyo, Dirk-Jan Eikema, Goda Choi, Ellen Meijer, Johanna Tischer, Luigi Rigacci, Firoozeh Sahebi, Patrick Hayden, Jaime Sanz Caballer, Stefan Schönland, Didier Blaise, Montserrat Rovira, Noel Milpied, David Valcárcel, Friedrich Stoelzel, Luca Castagna
Publikováno v:
Blood, 136. AMER SOC HEMATOLOGY
Introduction Acute and chronic graft vs. host disease (a/cGVHD) are major causes of treatment failure and non-relapse mortality (NRM) in multiple myeloma (MM) patients (pts) undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Use of
Autor:
Karl S. Peggs, Norbert Claude Gorin, Noel Milpied, Didier Blaise, Sebastian Giebel, Gilles Salles, Reinhard Marks, Patrice Chevallier, Herve Finel, William Arcese, Ariane Boumendil, Mohamed Amine Bekadja
Publikováno v:
Cytotherapy. 23(6)
Background aims: Around 50 000 autologous stem cell transplantations are done each year worldwide using cryopreserved peripheral blood stem cells (PBSCs). Cryopreservation is time-consuming and expensive. Since 2007, several retrospective studies hav
Autor:
Arnon Nagler, Mutlu Arat, Christophe Peczynski, Johanna Tischer, L. Castagna, Simon Piemontese, E. Polge, Yener Koc, Didier Blaise, M. Labopin, Zafer Gulbas, A. Ruggeri, Emanuele Angelucci, Bipin B. Savani, Benedetto Bruno, Ivetta Danylesko, Noel Milpied, Mohamad Mohty, Fabio Ciceri
Publikováno v:
Transplantation and Cellular Therapy. 27:S236-S237
Autor:
I. Yakoub-Agha, J Byrne, Hélène Labussière-Wallet, William Arcese, Tobias Gedde-Dahl, Jan J. Cornelissen, Riitta Niittyvuopio, Charles Craddock, Mohamad Mohty, Jordi Esteve, M. Labopin, Arnon Nagler, Jonathan Canaani, Gérard Socié, Noel Milpied
Publikováno v:
Transplantation and Cellular Therapy. 27:S55-S56
Autor:
Krimo Bouabdallah, Lucie Meynard, Francois-Xavier Gros, Mathieu Sauvezie, Noel Milpied, Jean Galtier, Sophie Dimicoli, Marie-Sarah Dilhuydy, Axelle Lascaux, Simon Favre, Lucile Debus
Publikováno v:
Leukemialymphoma. 61(13)
Elderly Hodgkin’s Lymphoma (HL), defined as occurring in patients over 60 years, represents 20% of all Hodgkin’s lymphoma cases and differ from younger HL in clinical, biological, pathological and ...
Autor:
Florent Malard, Christoph Schmid, Ali Bazarbachi, Gesine Bug, Dietrich W. Beelen, Uwe Platzbecker, Norbert Claude Gorin, Anne Huynh, Noel Milpied, Roni Shouval, Jan J. Cornelissen, Charles Craddock, Arnon Nagler, Myriam Labopin, Maria H. Gilleece, Riitta Niittyvuopio, Francesco Lanza, Eolia Brissot, Mohamad Mohty, Sebastian Giebel, Jordi Esteve, Alexandros Spyridonidis, Mahmoud Aljurf, J. Sanz, Didier Blaise, Arnold Ganser, Annalisa Ruggeri, Zinaida Peric, Jurjen Versluis, Bipin N. Savani, Fabio Ciceri, Yngvar Fløisand, Frédéric Baron, Laimonas Griskevicius, Gérard Socié
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, 2020, 55 (6), pp.1213-1213. ⟨10.1038/s41409-020-0835-3⟩
BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (6), pp.1213-1213. ⟨10.1038/s41409-020-0835-3⟩
Bone Marrow Transplantation, 2020, 55 (6), pp.1213-1213. ⟨10.1038/s41409-020-0835-3⟩
BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (6), pp.1213-1213. ⟨10.1038/s41409-020-0835-3⟩
In the original publication, the author Mahmoud Aljurf was omitted from the author list. This author’s affiliation is 'Oncology Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia'. This has been corrected in both the PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6624f1fef57187309600abb87818ecbb
https://hal-amu.archives-ouvertes.fr/hal-03152816
https://hal-amu.archives-ouvertes.fr/hal-03152816
Autor:
David B. Miklos, Henry C. Fung, Samantha Jaglowski, Lianqing Zheng, Amer Beitinjaneh, Arati V. Rao, Houston Holmes, Max S. Topp, John M. Pagel, Brian T. Hill, Javier Munoz, Roch Houot, Rajul K. Jain, Noel Milpied, Marie José Kersten, Weimin Peng, Caron A. Jacobson, Michael Wang, John M. Rossi, Frederick L. Locke, Patrick M. Reagan, Ian W. Flinn, John M. Timmerman, Peter A. McSweeney, Andre Goy
Publikováno v:
New England journal of medicine, 382(14), 1331-1342. Massachussetts Medical Society
BACKGROUND Patients with relapsed or refractory mantle-cell lymphoma who have disease progression during or after the receipt of Bruton's tyrosine kinase (BTK) inhibitor therapy have a poor prognosis. KTE-X19, an anti-CD19 chimeric antigen receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d56c829bd9f29c06272c5324d0d65d4
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
Autor:
Evelyne Marry, Catherine Faucher, Société Francophone de Greffe de Moelle et de Thérapie Cellulaire, Mohamad Mohty, Patrice Chevallier, Clémence Deteix, Alison M. Foote, Noel Milpied, Fabrice Larosa, Sabine Furst, Frédéric Garban, Ibrahim Yakoub-Agha, Anne Huynh, Sylvain Chantepie, Jean-Yves Cahn, Jacques-Olivier Bay, Régis Peffault de Latour, Nathalie Fegueux, Florence Mesnil, Hélène Labussière Wallet, Françoise Audat, Jean-Henri Bourhis
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (4), pp.749-757. ⟨10.1038/s41409-019-0722-y⟩
Bone Marrow Transplantation, Nature Publishing Group, 2020, 55 (4), pp.749-757. ⟨10.1038/s41409-019-0722-y⟩
Allogeneic hematopoietic stem cell transplantation is the only potentially curative therapy for high-risk acute myeloid leukemia. In the absence of an HLA-matched related or unrelated donor (MRD or MUD), the best alternative donor source remains cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366a0b66a50e7579491f0adef06d1579
https://hal.uca.fr/hal-02872489
https://hal.uca.fr/hal-02872489
Autor:
Mauricette Michallet, Mathilde Hunault-Berger, Nicolaus Kröger, Jörg Cammenga, Johan Maertens, Monique C. Minnema, Jakob Passweg, Joan Hendrik Veelken, Riitta Niittyvuopio, Anja van Biezen, Stefan Schönland, Francisco José Márquez-Malaver, Simona Iacobelli, Arancha Bermúdez, Stéphanie Nguyen, Didier Blaise, Dietger Niederwieser, Ibrahim Yakoub-Agha, Noel Milpied, Patrick Hayden, Laurent Garderet, Yves Chalandon, Ellen Meijer, José Antonio Pérez-Simón, Jean Bourhis
Publikováno v:
Hayden, P J, Iacobelli, S, Pérez-Simón, J A, van Biezen, A, Minnema, M, Niittyvuopio, R, Schönland, S, Meijer, E, Blaise, D, Milpied, N, Márquez-Malaver, F J, Veelken, J H, Maertens, J, Michallet, M, Cammenga, J R, N'Guyen, S, Niederwieser, D, Hunault-Berger, M, Bourhis, J H, Passweg, J, Bermudez, A, Chalandon, Y, Yakoub-Agha, I, Garderet, L & Kröger, N 2020, ' Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP ', European Journal of Haematology, vol. 104, no. 3, pp. 181-189 . https://doi.org/10.1111/ejh.13352
European Journal of Haematology
European Journal of Haematology, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
European Journal of Haematology, 104(3), 181-189. Wiley-Blackwell
European Journal of Haematology, 104(3), 181. Wiley-Blackwell
European Journal of Haematology, Vol. 104, No 3 (2020) pp. 181-189
European Journal of Haematology, Wiley, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
European Journal of Haematology. WILEY
European Journal of Haematology
European Journal of Haematology, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
European Journal of Haematology, 104(3), 181-189. Wiley-Blackwell
European Journal of Haematology, 104(3), 181. Wiley-Blackwell
European Journal of Haematology, Vol. 104, No 3 (2020) pp. 181-189
European Journal of Haematology, Wiley, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
European Journal of Haematology. WILEY
[Objectives] The aim of this study was to compare the effect of the intensity of conditioning approaches used in allogeneic transplantation in myeloma—reduced intensity conditioning (RIC), non‐myeloablative (NMA), myeloablative conditioning (MAC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465bcde0e81b55721a1f57e75c6e69cf
https://research.vumc.nl/en/publications/bcb5e8f0-4a5a-40fc-b72c-81940d8276fc
https://research.vumc.nl/en/publications/bcb5e8f0-4a5a-40fc-b72c-81940d8276fc